Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2018

View Archived Issues

Taking the STING out of autoimmunity

Universiteit Twente presents an ITGA5-binding peptide for pancreatic cancer

New EGFR-TKI to treat T790M-mediated resistant lung cancers

Arsanis describes monoclonal antibody binding Spa and Sbi which protects against S. aureus

ETX-1317 restores the activity of cefpodoxime against beta-lactamase-producing UTI isolates

Homozygous mutation of the TALDO1 gene linked to transladolase deficiency in an adult woman

New missense variant in the FBXW11 gene associated with developmental eye and limb anomalies

Homozygous mutations in SLC10A7 gene linked to skeletal dysplasia

mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical

Fatty acid synthase inhibitors synthesized at Cephalon

Orion initiates phase III REFALS study of oral levosimendan for the treatment of ALS

Leo Pharma presents phosphodiesterase PDE4 inhibitors

Hangzhou Innogate Pharma divulges protein kinase inhibitors

Dual GLP-1R/GCGR agonist may help to improve the control of postprandial glucose in type 2 diabetes

Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands

New mutant EGFR inhibitors identified at Medshine Discovery

Phase II trial of ZGN-1061 in obesity and diabetes meets all primary objectives at interim analysis

Galapagos outlines phase II trial of GLPG-1205 in IPF

Benitec and Axovant sign licensing agreement for BB-301 and partner on further gene therapy programs

Incyte studies INCB-081776 for advanced solid tumors in phase I

Bayer initiates first-in-human study with BAY-1830839

Tegoprazan approved for the treatment of GERD in Korea

FDA lifts clinical hold on Invossa trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...